预测减肥手术后的严重并发症风险:使用荷兰肥胖治疗审计对密歇根减肥手术协作风险预测模型进行外部验证
Predicting serious complication risks after bariatric surgery: external validation of the Michigan Bariatric Surgery Collaborative risk prediction model using the Dutch Audit for Treatment of Obesity.
作者信息
Akpinar Erman O, Ghaferi Amir A, Liem Ronald S L, Bonham Aaron J, Nienhuijs Simon W, Greve Jan Willem M, Marang-van de Mheen Perla J
机构信息
Department of Surgery, Maastricht University Medical Center, NUTRIM School for Nutrition and Translational Research in Metabolism, Maastricht, The Netherlands; Scientific Bureau, Dutch Institute for Clinical Auditing, Leiden, The Netherlands.
Department of Surgery, University of Michigan, Ann Arbor, Michigan.
出版信息
Surg Obes Relat Dis. 2023 Mar;19(3):212-221. doi: 10.1016/j.soard.2022.09.008. Epub 2022 Sep 15.
BACKGROUND
Risk-prediction tools can support doctor-patient (shared) decision making in clinical practice by providing information on complication risks for different types of bariatric surgery. However, external validation is imperative to ensure the generalizability of predictions in a new patient population.
OBJECTIVE
To perform an external validation of the risk-prediction model for serious complications from the Michigan Bariatric Surgery Collaborative (MBSC) for Dutch bariatric patients using the nationwide Dutch Audit for Treatment of Obesity (DATO).
SETTING
Population-based study, including all 18 hospitals performing bariatric surgery in the Netherlands.
METHODS
All patients registered in the DATO undergoing bariatric surgery between 2015 and 2020 were included as the validation cohort. Serious complications included, among others, abdominal abscess, bowel obstruction, leak, and bleeding. Three risk-prediction models were validated: (1) the original MBSC model from 2011, (2) the original MBSC model including the same variables but updated to more recent patients (2015-2020), and (3) the current MBSC model. The following predictors from the MBSC model were available in the DATO: age, sex, procedure type, cardiovascular disease, and pulmonary disease. Model performance was determined using the area under the curve (AUC) to assess discrimination (i.e., the ability to distinguish patients with events from those without events) and a graphical plot to assess calibration (i.e., whether the predicted absolute risk for patients was similar to the observed prevalence of the outcome).
RESULTS
The DATO validation cohort included 51,291 patients. Overall, 986 patients (1.92%) experienced serious complications. The original MBSC model, which was extended with the predictors "GERD (yes/no)," "OSAS (yes/no)," "hypertension (yes/no)," and "renal disease (yes/no)," showed the best validation results. This model had a good calibration and an AUC of .602 compared with an AUC of .65 and moderate to good calibration in the Michigan model.
CONCLUSION
The DATO prediction model has good calibration but moderate discrimination. To be used in clinical practice, good calibration is essential to accurately predict individual risks in a real-world setting. Therefore, this model could provide valuable information for bariatric surgeons as part of shared decision making in daily practice.
背景
风险预测工具可通过提供不同类型减肥手术并发症风险的信息,支持临床实践中的医患(共同)决策。然而,外部验证对于确保预测在新患者群体中的可推广性至关重要。
目的
使用荷兰全国肥胖治疗审计(DATO)对密歇根减肥手术协作组(MBSC)针对荷兰减肥患者的严重并发症风险预测模型进行外部验证。
设置
基于人群的研究,纳入荷兰所有18家进行减肥手术的医院。
方法
将2015年至2020年间在DATO登记接受减肥手术的所有患者纳入验证队列。严重并发症包括腹部脓肿、肠梗阻、渗漏和出血等。验证了三个风险预测模型:(1)2011年的原始MBSC模型;(2)包含相同变量但更新至近期患者(2015 - 2020年)的原始MBSC模型;(3)当前的MBSC模型。DATO中可获取MBSC模型的以下预测因素:年龄、性别、手术类型、心血管疾病和肺部疾病。使用曲线下面积(AUC)来评估辨别力(即区分发生事件的患者与未发生事件的患者的能力),并通过绘制图表来评估校准(即患者的预测绝对风险是否与观察到的结局患病率相似),以此确定模型性能。
结果
DATO验证队列包括51,291名患者。总体而言,986名患者(1.92%)发生了严重并发症。扩展了预测因素“胃食管反流病(是/否)”“阻塞性睡眠呼吸暂停综合征(是/否)”“高血压(是/否)”和“肾病(是/否)”的原始MBSC模型显示出最佳验证结果。该模型校准良好,AUC为0.602,而密歇根模型的AUC为0.65,校准为中度至良好。
结论
DATO预测模型校准良好,但辨别力中等。要在临床实践中使用,良好的校准对于在实际环境中准确预测个体风险至关重要。因此,作为日常实践中共同决策的一部分,该模型可为减肥外科医生提供有价值的信息。